Literature DB >> 2104684

Molecular characterization of the RNA S segment of nephropathia epidemica virus strain Hällnäs B1.

R Stohwasser1, L B Giebel, L Zöller, E K Bautz, G Darai.   

Abstract

The S segment RNA of nephropathia epidemica virus (NEV) strain Hällnäs B1 was isolated by molecular cloning of the corresponding cDNA. The RNA is 1785 nucleotides long with the 3' and 5' termini being complementary for 23 bases. The viral messenger-sense RNA contains one major open reading frame (ORF) with a coding capacity of 433 amino acids encoding a 49-kDa polypeptide. Compared to the Hantaan S segment cDNA sequence there is a nucleotide homology of 60 and 61% at the amino acid level. Many of the amino acid differences are conservative exchanges. The C-termini of the NEV and Hantaan nucleocapsid proteins are nearly identical and the hydrophilicity profiles are very similar. In contrast, the following differences are significant: The calculated isoelectric points of the NEV and Hantaan nucleocapsid proteins are 5.6 and 6.7, respectively. The most prominent antigenic determinants predicted by the hydrophilicity profiles are located close to the C-terminus of NEV and close to the N-terminus of Hantaan virus nucleocapsid polypeptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104684     DOI: 10.1016/0042-6822(90)90056-w

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein.

Authors:  P Gött; L Zöller; G Darai; E K Bautz
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

3.  Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype.

Authors:  A Reip; B Haring; C Sibold; R Stohwasser; E K Bautz; G Darai; H Meisel; D H Krüger
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay.

Authors:  L Zöller; M Faulde; H Meisel; B Ruh; P Kimmig; U Schelling; M Zeier; P Kulzer; C Becker; M Roggendorf
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

5.  First molecular evidence for Puumala hantavirus in Slovakia.

Authors:  K Leitmeyer; C Sibold; H Meisel; R Ulrich; M Labuda; D H Krüger
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

6.  A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana.

Authors:  S P Morzunov; H Feldmann; C F Spiropoulou; V A Semenova; P E Rollin; T G Ksiazek; C J Peters; S T Nichol
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 7.  New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention--a review.

Authors:  Martin Zeier; Michaela Handermann; Udo Bahr; Baldur Rensch; Sandra Müller; Roland Kehm; Walter Muranyi; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

8.  Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia.

Authors:  C Sibold; H Meisel; D H Krüger; M Labuda; J Lysy; O Kozuch; M Pejcoch; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Identification and characterization of a Hantavirus strain of unknown origin by nucleotide sequence analysis of the cDNA derived from the viral S RNA segment.

Authors:  L B Giebel; K Raab; L Zöller; E K Bautz; G Darai
Journal:  Virus Genes       Date:  1991-04       Impact factor: 2.332

10.  Detection and subsequent sequencing of Puumala virus from human specimens by PCR.

Authors:  J Hörling; A Lundkvist; K Persson; M Mullaart; T Dzagurova; A Dekonenko; E Tkachenko; B Niklasson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.